bioRxiv Science⌕ Search

Biology subjects

Pumpe, C.

Publications and source records attributed to Pumpe, C..

3 recordsLinked to original sources

Sex-specific regulation of macrophage function determines outcome to acute bacterial infection

Sex differences in infection outcome are widespread across sexually reproducing animals. The immune mechanisms generating these differences remain incompletely understood, in part because it is challenging to decompose systemic effects from cell-intrinsic regulation in mammalian model systems and clinical data. Sex-biased infection outcomes are observed in taxa lacking adaptive immunity, suggesting that innate immune cells, such as macrophages, have the potential to drive dimorphisms. It is largely unknown whether macrophage-intrinsic sex identity is causal for infection susceptibility, or for sex differences in other, homeostatic functions. Here, we address this question using Drosophila melanogaster, an in vivo model of innate immunity where sex is established, and can be manipulated, cell-autonomously. We show that during infection by the bacterium Staphylococcus aureus, adult male flies succumb faster than females, with more rapid early bacterial proliferation. Hemocyte ablation reveals that survival is hemocyte-dependent in both sexes, and flow cytometry indicates a higher fraction of actively phagocytic hemocytes in females. Critically, genetically feminizing male hemocytes abolishes the dimorphism in survival and bacterial burden in S. aureus infection, bringing feminized males to the equivalent load and mortality risk as females. Transcriptomic analysis of whole carcasses shows strongly sex-biased responses during S. aureus infection, whereas hemocyte-specific RNA-sequencing reveals minimal sex differences in induced responses but substantial, sustained baseline transcriptomic divergence, including female-biased expression of bactericidal mechanisms linked to ROS generation and lysozyme production. Together, these findings demonstrate that the sex identity of innate immune cells is sufficient to shape infection outcome.

immunology↗

Rheumatoid Arthritis-associated IgG N-glycan agalactosylation diminishes neutrophilic inflammation by reducing FcgammaR binding and downstream signaling

The IgG Fc chain carries a single N-linked glycan which may undergo changes. Increased agalactosylated N-glycans are associated with rheumatoid arthritis (RA) and regarded as pro-inflammatory. Dysregulated neutrophils can make important contributions to host tissue damage. In RA, immune complexes (ICs) that have precipitated onto synovial joint surfaces activate neutrophils via Fc receptors, promoting localised inflammation. We engineered recombinant human monoclonal IgG with agalactosylated or galactosylated N-glycans, generated immobilised ICs and stimulated healthy donor and RA patient blood-derived neutrophils, comparing reactive oxygen species (ROS) production as read-out of neutrophilic inflammation. Both healthy donor and RA patient neutrophils generated less ROS when stimulated with ICs made from agalactosylated IgG. Mechanistically this was due to poorer binding of agalactosylated ICs to neutrophil Fc{gamma}Rs, causing lower activation of Akt and p38 MAPK. Both are required for immobilised IC-mediated stimulation of the neutrophil NADPH oxidase. Taken together, this suggests that disease-associated, agalactosylated IgG does not in fact promote inflammation and host tissue injury, at least not by acting on neutrophils. We propose that rather than promoting inflammation, agalactosylated IgG N-glycans that accompany inflammatory disease may arise as part of a compensatory mechanism that is aimed at reducing excessive inflammation and host tissue injury. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=199 SRC="FIGDIR/small/735866v1_ufig1.gif" ALT="Figure 1"> View larger version (56K): org.highwire.dtl.DTLVardef@18a7178org.highwire.dtl.DTLVardef@1f8d75org.highwire.dtl.DTLVardef@1801a22org.highwire.dtl.DTLVardef@133e657_HPS_FORMAT_FIGEXP M_FIG C_FIG

immunology↗

Plasma Cell-Free DNA in Acute and Chronic Aortic Syndromes.

Acute aortic syndromes and other acute aortic events are commonly misdiagnosed and associated with high mortality and morbidity. There is need for a blood-based biomarker to indicate the acutely unstable aorta. Plasma cell-free DNA (cfDNA) is an established diagnostic marker in prenatal testing and cancer. Its use as a potential diagnostic marker in aortic disease remains to be demonstrated. We found that plasma short-fragment (50-700bp) cfDNA concentration is significantly increased in patients with both acute and chronic aortic disease compared with several control groups, and is significantly increased in acute versus chronic aortic disease. Plasma sf-cfDNA may differentiate acute aortic syndromes from other acute presentations of chest pain with good diagnostic accuracy and could prove a significant advance in the management of aortic disease.

genomics↗